Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALCIDION GROUP LIMITED Board/Management Information 2021

May 27, 2021

64360_rns_2021-05-27_df881758-ddbe-42f7-b443-92d736a5c2ff.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [166 x 43] intentionally omitted <==

28 May 2021

Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000

Appointment of Chief Financial Officer

Melbourne, Australia – Alcidion Group Limited (ASX: ALC) is pleased to announce it has further strengthened the management team with the appointment of experienced senior finance professional Matthew Gepp as its Chief Financial Officer (CFO), effective 7 June 2021.

Colin MacKinnon, who currently holds the dual role of Chief Operating Officer (COO) and CFO, will continue as COO overseeing the group’s operations.

This appointment supports Alcidion’s planned growth objectives, allowing Colin to focus full time on his role as COO, particularly as operations in Australia and the UK continue to accelerate.

Mr Gepp joins Alcidion with 17 years’ experience holding senior finance and leadership positions, including as the CFO of ASX listed technology and software companies, MNF Group Limited and Engin Limited, and 10 years of international experience in financial and operational roles in London and Europe.

Mr Gepp has a proven track record of delivering upon financial objectives and in his most recent position as CFO of MNF Group, oversaw the successful acquisition and integration of several businesses as part of their growth strategy.

Mr Gepp is a member of Chartered Accountants Australia & New Zealand and holds a Bachelor of Economics (Accounting) from Macquarie University.

Alcidion Managing Director Kate Quirke said, “I am very pleased to welcome Matthew to Alcidion as Chief Financial Officer. After a considered recruitment process, Matthew was identified as an excellent candidate due to his extensive experience with ASX listed companies in the technology and software sectors, helping them to scale organically and through acquisition and operate across international markets.”

“I look forward to working with Matthew, both as a member of our Senior Leadership Team and as advisor to the Board, as we continue to transform the delivery of healthcare and execute upon our objectives of becoming a leading global healthcare organisation.”

ENDS

For further information, please contact:

Kyahn Williamson

WE Communications Ph: +61 401 018 828 [email protected]

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [110 x 29] intentionally omitted <==

About Alcidion Group Limited (ASX:ALC)

Alcidion Group Limited (Alcidion) has a simple purpose: to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

© Alcidion Group Limited 2021. Alcidion, Miya Precision, Patientrack and Smartpage are registered trademarks. All other brands and product names and trademarks are the registered property of their respective companies.

This announcement is authorised for release by the Board of Directors of Alcidion Group Limited.

Page 2